Year in review
2017: the year in pharmacy

Shutterstock.com
- Previous
- Next
-
January 2017
Shutterstock.com
-
February 2017
Courtesy of Ken Jarrold, Shutterstock.com
-
March 2017
Shutterstock.com
-
April 2017
Shutterstock.com
-
May 2017
Alamy Stock Photo (WHO) and MAG / The Pharmaceutical Journal (Robbie Turner)
-
June 2017
Wikimedia Commons
-
July 2017
Wikimedia Commons
-
August 2017
Shutterstock.com
-
September 2017
Shutterstock.com
-
October 2017
Shutterstock.com
-
November 2017
EMA (Guido Rasi) and MAG / The Pharmaceutical Journal (Paul Bennett)
-
December 2017
Shutterstock.com
Against a backdrop of political inertia caused by a surprise general election and protracted Brexit negotiations, pharmacy has been grappling with some major issues of its own, including supervision of medicines supply, professional revalidation and decriminalisation of dispensing errors (see 2017: Pharmacy’s roller-coaster year). Antimicrobial resistance and integration of primary care services have also been high on pharmacy’s agenda, as has a consultation on government plans to take low-value medicines and cheaper, over-the-counter products off prescription. Track the main developments on these issues using our timeline above (click arrows at the top right of the main image to view in expanded mode).
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20204109
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.